AOA Dx ventures to diagnose ovarian cancer - Episode 120

FemTech Focus

AOA is a team of entrepreneurs and experts that bring innovative, impactful and cost-effective medical technologies from research and development into the hands of providers and patients. AOA's mission is to bring to market the first accurate early stage ovarian cancer diagnostic test that will improve clinical practice, help reduce patient mortality and deliver cost savings to payers.Their first product, is the first liquid biopsy test that accurately enables early diagnosis of ovarian cancer through the analysis of tumor marker gangliosides. This episode features an interview with Oriana Papin-Zoghbi, the CEO and Co-Founder of AOA Dx. She has global experience creating and leading teams and organizations resulting in successful strategic exits. ​Oriana brings a wealth of knowledge and expertise from women's health startups and large life science companies, and a passion for entrepreneurship and solving problems that disproportionately affect women.